Estimation of the Difference in Colistin Plasma Levels in Critically Ill Patients with Favorable or Unfavorable Clinical Outcomes

In recent decades, antimicrobial resistance (AMR) has led to an increased use of therapeutic alternatives. Among these options, colistin continues to be an option for the treatment of multi-resistant (MDR) Gram-negative bacterial infections. However, due to its high toxicity (nephrotoxicity and neur...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanabria, Jose, Garzón, Vivian, Pacheco, Tatiana, Avila, Maria-Paula, Garcia, Julio-Cesar, Jaimes, Diego, Torres, Angela, Bustos, Rosa-Helena, Escobar-Perez, Javier, Abril, Deisy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540821/
https://www.ncbi.nlm.nih.gov/pubmed/34683923
http://dx.doi.org/10.3390/pharmaceutics13101630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540821/
https://www.ncbi.nlm.nih.gov/pubmed/34683923
http://dx.doi.org/10.3390/pharmaceutics13101630

Ejemplares similares